Legal opinion on the cancellation of limited share repurchase of Jiangzhong Pharmaceutical's 2021 restricted stock incentive plan.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.